Chronic lung diseases are the third leading cause of death worldwide and are increasing in prevalence over time. Although much of our traditional understanding of health and disease …
JD Chalmers, ML Crichton… - European respiratory …, 2021 - Eur Respiratory Soc
Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …
Background SARS-CoV-2 infection represents a global health problem that has affected millions of people. The fine host immune response and its association with the disease …
N Roche, ML Crichton, PC Goeminne… - European respiratory …, 2022 - Eur Respiratory Soc
Since the identification of SARS-CoV-2 at the end of 2019, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 410 million people worldwide and killed …
M Trunfio, F Venuti, F Alladio, BM Longo, E Burdino… - Viruses, 2021 - mdpi.com
To date, there is no severe acute respiratory syndrome coronavirus 2-(SARS-CoV-2)- specific prognostic biomarker available. We assessed whether SARS-CoV-2 cycle threshold …
Introduction We sought to provide the first report of the use of NEWS2 monitoring to pre- emptively identify clinical deterioration within hospitalised COVID-19 patients. Methods …
A Artero, M Madrazo, M Fernández-Garcés… - Journal of general …, 2021 - Springer
Background Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been …
A Lim, A Radujkovic, MA Weigand, U Merle - Annals of Intensive Care, 2021 - Springer
Background COVID-19 pneumonia and subsequent respiratory failure is causing an immense strain on intensive care units globally. Early prediction of severe disease enables …
Background The WHO ordinal severity scale has been used to predict mortality and guide trials in COVID-19. However, it has its limitations. Objective The present study aims to …